neratinib-based combination therapy in her2-mutant lung cancer
Published 3 years ago • 198 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
21:00
gs4 10 neratinib fulvestrant trastuzumab for hormone receptor-positive, her2-mutant metastatic
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
2:34
eleanor: real-world use of neratinib in her2 , early breast cancer
-
7:30
neratinib plus fulvestrant for her2 mutant, non-amplified metastatic breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
1:24
dr davis on the investigation of neratinib trastuzumab deruxtecan in advanced her2 solid tumors
-
2:14
neratinib in her2 or her3 mutant solid tumours
-
3:49
zenith20: poziotinib in egfr and her2 exon 20 mutant nsclc
-
4:52
neratinib fulvestrant trastuzumab for hr her2-mutant mbc and neratinib trastuzumab for tr...
-
3:25
role for neratinib following adjuvant dual-targeted her2 therapy
-
3:15
neratinib for metastatic breast cancer
-
6:49
treating her2-mutant advanced biliary tract cancer with neratinib
-
4:24
zenith20-4: efficacy & safety of poziotinib in treatment-naïve nsclc with her2 exon 20 mutations
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
6:29
case based panel discussion nsclc – does a positive her2 mutation effect treatment decisions?
-
7:25
neratinib capecitabine in her2 breast cancer
-
1:41
what is a her2 mutation in lung cancer?